Xechem International Inc. (fka XKEM)

[Spacely]

November 29, 2006 02:00 PM Eastern Time
NYSSA Presents 10th Annual Biotech/Specialty Pharma Conference
Biotech/Specialty Pharma Conference
NEW YORK--(BUSINESS WIRE)--The New York Society of Security Analysts (NYSSA) will present the 10th Annual Biotech/Specialty Pharma Conference on December 12 to 13, 2006.

What does the future have in store for the biotech industry? Don’t miss this chance to hear Michael D. West, PhD, president of Advanced Cell Technology and author of The Immortal Cell: One Scientist’s Quest to Solve the Mystery of Human Aging, discuss the emerging field of stem cell research. Other presentations include companies focused on hormone therapy, drug delivery and treatments for HIV/AIDS and cancer.

The following companies are presenting on day one:

Aradigm Corporation (Nasdaq: ARDM); BioSante Pharmaceuticals, Inc. (AMEX: BPA); CytRx Corporation (Nasdaq: CYTR); DNAPrint Genomics, Inc. (OTCBB: DNAG); DRAXIS Health Inc. (Nasdaq: DRAX; TSX: DAX); DURECT Corporation (Nasdaq: DRRX); Heska Corporation (Nasdaq: HSKA); The Immune Response Corporation (OTCBB: IMNR); Viral Genetics, Inc. (OTCBB: VRAL); and Xechem International, Inc. (OTCBB: XKEM).

The following companies are presenting on day two:

Advanced Cell Technology, Inc. (OTCBB: ACTC); Cleveland BioLabs, Inc. (Nasdaq: CBLI); Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC); EntreMed, Inc. (Nasdaq: ENMD); Neuro-Hitech Pharmaceuticals, Inc. (OTCBB: NHPI); Provectus Pharmaceuticals, Inc. (OTCBB: PVCT); The Quigley Corporation (Nasdaq: QGLY); and XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB).

The conference will be held on December 12, 2006, 8:30 a.m. to 5:10 p.m., and December 13, 2006, 8:30 a.m. to 4:30 p.m. at NYSSA, 1177 Avenue of the Americas, 2nd Floor, NYC. Registration deadline is December 5, one day, $265 NYSSA members, $365 nonmembers; two days, $365 NYSSA members, $465 nonmembers. No charge for press with credentials. A complete agenda is available at

http://www.nyssa.org/Template.cfm?Section=conferences___ seminars&template=/ContentManagement/ContentDisplay.cfm&ContentID=8977

About NYSSA

NYSSA, established in 1937, is the premier independent forum for the exchange of information among investment decision-makers. A not-for-profit educational organization with over 9,500 members, NYSSA is committed to the promotion of best practices and the highest professional and ethical standards in the investment industry. NYSSA is the largest of the more than 134 societies worldwide that make up CFA Institute, which has more than 83,000 members.